BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2012
View Archived Issues
Team at Merrimack Pharmaceuticals designs new bispecific antibodies
Read More
AstraZeneca profiles novel dual chemokine CCR3/histamine H1 receptor antagonists
Read More
Gilead's GS-967 suppresses experimental arrhythmias
Read More
New TRPV4 channel ligands divulged by Shionogi
Read More
Promising results presented for a novel malaria vaccine
Read More
Novel antipsychotics created at Roche
Read More
King Saud University and Terramark design new anti-inflammatory agents
Read More
Arena Pharmaceuticals divulges novel GRP119 receptor agonists
Read More
Ligand Pharmaceuticals presents a novel HepDirect prodrug with excellent oral bioavailability
Read More
Enhanced genetically encoded calcium indicators described / News in Context: Optogenetics
Read More
ImmunoGen patents novel cancer therapeutics
Read More
New antivirals designed by University of Pennsylvania
Read More
University of Missouri discloses novel TNF-alpha production inhibitors
Read More
EMA recommends granting orphan status to Aspireo's somatoprim
Read More
GS-432780-5 and GS-443023-6 show promise in mouse models of chronic liver injury
Read More
Alfama designs novel therapy against liver pathology
Read More
Discovery of AZ-12436092 reported by AstraZeneca researchers
Read More
Pharming receives milestone payment from Santarus
Read More
CLSPN gene mutations identified in glioma patients
Read More
Phase IIb JX-594 trial begins in Hong Kong
Read More
Murdoch Childrens opens Australian site in global study of BioMarin's achondroplasia treatment
Read More
AstraZeneca and Pfizer partnership establishes life sciences research center
Read More
Recruitment complete in phase I study of ATX-MS-1467
Read More